The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Self-citationThe Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Meta-analysis: Principles and procedures
Egger, M., Smith, G. D., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7121.1533 · Cited by 2,415
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302 · cited 3×
“In our meta-analysis, we have not included these five small studies of patients with biopsy-proven NAFLD because they lacked an adequate control group [31-35].”
BackgroundHernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · Hepatology · doi:10.1002/hep.24452 · Cited by 1,585
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
Self-citationThe economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Younossi, Z. M., Blissett, D., Blissett, R., Henry, L., Stepanova, M., Younossi, Y., Racila, A., Hunt, S., & Beckerman, R. (2016) · Hepatology · doi:10.1002/hep.28785 · Cited by 1,285
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Self-citationMills, K. T., Xu, Y., Zhang, W., Bundy, J. D., Chen, C.-S., Kelly, T. N., Chen, J., & He, J. (2015) · Kidney International · doi:10.1038/ki.2015.230 · Cited by 865
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. (2010) · Hepatology · doi:10.1002/hep.23314 · Cited by 754
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
Self-citationMusso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001680 · Cited by 720
Wong, V. W.-S., Wong, G. L.-H., Choi, P. C.-L., Chan, A. W.-H., Li, M. K.-P., Chan, H.-Y., Chim, A. M.-L., Yu, J., Sung, J. J.-Y., & Chan, H. L.-Y. (2010) · Gut · doi:10.1136/gut.2009.205088 · Cited by 648
Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance
Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631 · cited 1×
“mediators that play important roles in the pathophysiology of CKD and other extra-hepatic vascular complications [5-7,11,39-44].”
BackgroundEarly recognition and prevention of chronic kidney disease
James, M. T., Hemmelgarn, B. R., & Tonelli, M. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62004-3 · Cited by 606
The global burden of chronic kidney disease: estimates, variability and pitfalls
Glassock, R. J., Warnock, D. G., & Delanaye, P. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.163 · Cited by 511
Angulo, P., Bugianesi, E., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Barrera, F., Haflidadottir, S., Day, C. P., & George, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.057 · Cited by 502
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez-Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444
Self-citationNon-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal
Machado, M. V., & Cortez-Pinto, H. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.021 · Cited by 412
Roles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
Targher, G., & Byrne, C. D. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.16 · Cited by 309
Self-citationAssessment of Glomerular Filtration Rate in Health and Disease: A State of the Art Review
Levey, A., & Inker, L. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.729 · Cited by 244
Non-alcoholic fatty liver disease and risk of cardiovascular disease
Lonardo, A., Sookoian, S., Pirola, C. J., & Targher, G. (2016) · Metabolism · doi:10.1016/j.metabol.2015.09.017 · Cited by 236
Self-citationIncreased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M., Bertolini, L., Rodella, S., Zenari, L., Lippi, G., Franchini, M., Zoppini, G., & Muggeo, M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101155 · Cited by 232
Self-citationRyu, S., Chang, Y., Kim, D.-I., Kim, W. S., & Suh, B.-S. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.078980 · Cited by 217
CKD and Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M. B., & Byrne, C. D. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.019 · Cited by 213
Self-citationByrne, C. D., & Targher, G. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303034 · Cited by 179
Self-citationSinn, D. H., Kang, D., Jang, H. R., Gu, S., Cho, S. J., Paik, S. W., Ryu, S., Chang, Y., Lazo, M., Guallar, E., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.024 · Cited by 165
Chang, Y., Ryu, S., Sung, E., Woo, H.-Y., Oh, E., Cha, K., Jung, E., & Kim, W. S. (2008) · Metabolism · doi:10.1016/j.metabol.2007.11.022 · Cited by 164
Targher, G., Mantovani, A., Pichiri, I., Mingolla, L., Cavalieri, V., Mantovani, W., Pancheri, S., Trombetta, M., Zoppini, G., Chonchol, M., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2704 · Cited by 162
Self-citationFatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities
Musso, G., Cassader, M., Cohney, S., De Michieli, F., Pinach, S., Saba, F., & Gambino, R. (2016) · Diabetes Care · doi:10.2337/dc15-1182 · Cited by 161
Ballestri, S., Nascimbeni, F., Baldelli, E., Marrazzo, A., Romagnoli, D., Targher, G., & Lonardo, A. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.003 · Cited by 159
Self-citationSerum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
Tahan, V., Canbakan, B., Balcı, H., Dane, F., Akın, H., Can, G., Hatemı, İ., Olgaç, V., Sonsuz, A., Özbay, G., et al. (2008) · PubMed · Cited by 100
Gómez, E. V., Bertot, L. C., Friedman, S. L., Gra‐Oramas, B., Gonzalez‐Fabian, L., Villa-Jiménez, O. M., del Vallín, S. L., Diago, M., Adams, L. A., Romero‐Gómez, M., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13860 · Cited by 71
Lee, D., Jacobs, D. R., Gross, M., & Steffes, M. W. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.045872 · Cited by 68
Huh, J. H., Kim, J., Choi, E. H., Kim, J. S., Chang, Y., & Sung, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180951 · Cited by 67
Arase, Y., Suzuki, F., Kobayashi, M., Suzuki, Y., Kawamura, Y., Matsumoto, N., Akuta, N., Kobayashi, M., Sezaki, H., Saito, S., et al. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5043 · Cited by 60
Azeem, H. A. E., Khalek, E.-S. A., El-Akabawy, H., Na'eim, H., Khalik, H. A., & Alfifi, A. A. (2013) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2013.07.004 · Cited by 57
Musso, G., Michieli, F. D., Bongiovanni, D., Parente, R., Framarin, L., Leone, N., Berrutti, M., Gambino, R., Cassader, M., Cohney, S. J., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.08.002 · Cited by 38
Gamma-glutamyltransferase and risk of chronic kidney disease: A prospective cohort study
Kunutsor, S. K., & Laukkanen, J. A. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.08.014 · Cited by 37
Shen, Z., Xing, J., Wang, Q., Faheem, A., Ji, X., Li, J., Bian, W., Jiang, Z., Li, X., Xue, F., et al. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1429-2 · Cited by 28
Maiwall, R., & Gupta, M. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.10.11 · Cited by 6
Cited by
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
Kuchay, M. S., Krishan, S., Mishra, S. K., Farooqui, K. J., Singh, M. K., Wasir, J. S., Bansal, B., Kaur, P., Jevalikar, G., Gill, H. K., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0165 · Cited by 662
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Mantovani, A., Scorletti, E., Mosca, A., Alisi, A., Byrne, C. D., & Targher, G. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154170 · Cited by 553
Self-citationMantovani, A., Petracca, G., Beatrice, G., Tilg, H., Byrne, C. D., & Targher, G. (2021) · Gut · doi:10.1136/gutjnl-2020-322572 · Cited by 481
Self-citationNAFLD as a driver of chronic kidney disease
Byrne, C. D., & Targher, G. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.013 · Cited by 449
Metadata
- Authors
- Mantovani, A., Zaza, G., Byrne, C. D., Lonardo, A., Zoppini, G., Bonora, E., & Targher, G.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 79
- Pages
- 64-76
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2767917689
- Cited by
- 348
- References
- 46
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.